Skip Navigation


Rheumatology Advance Access originally published online on December 23, 2008
Rheumatology 2009 48(3):323-324; doi:10.1093/rheumatology/ken447
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
48/3/323-a    most recent
ken447v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Urrutia, G.
Right arrow Articles by Alegre, C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Urrutia, G.
Right arrow Articles by Alegre, C.
Related Collections
Right arrow Fibromyalgia
Right arrow Pharmacology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Comment on: Amitriptyline in the treatment of fibromyalgia: a systematic review of its efficacy: reply

G. Urrutia1, B. Walitt1, B. Nishishinya1, A. Rodríguez1, X. Bonfill1, G. Darko1 and C. Alegre1

1Hospital de Sant Pau – Iberoamerican Cochrane Center, Barcelona, Spain

Correspondence to: G. Urrutia, Hospital de Sant Pau – Iberoamerican Cochrane Center, Sant Antoni M. Claret 171, Barcelona 08041, Spain. E-mail: gurrutia@santpau.es

The first 10% of the full text of this article appears below.

SIR, As Fontanelle and colleagues [1] point out, the results of our review [2] show that there is no objective evidence supporting the long-term efficacy of amitriptyline at a . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?